Emerging targets in the treatment of hepatitis C virus infection

Expert Opinion on Therapeutic Targets

Volumn 2, Issue 2, 1998, Pages 125-136

  Le, Hung V ^a   Weber, Patricia C ^a   Yao, Nanhua ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000959016     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1517/14728222.2.2.125     Document Type: Article

References (80)

1. ALTER MJ: Epidemiology of hepatitis C. Hepatology (1977) 26(3, Suppl. 1):62-65.
2. NATIONAL INSTITUTE OF HEALTH CONSENSUS DEVELOPMENT CONFERENCE PANEL STATEMENT: Management of hepatitis C. Hepatology (1977) 26(3, Suppl. 1):2-10.
3. REICHARD O, SCHVARCZ R, WEILAND O: Therapy of hepatitis C: alpha interferon and ribavirin. Hepatology (1977) 26(3, Suppl. 1):108-111.
4. ALTER MJ, MAST EE: The epidemiology of viral hepatitis in the United States. Gastroenterol. Clin. North Am. (1994) 23:435-437.
5. CHOO Q-L, KUO G, WEINER AJ et al.: Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science (1989) 244:359-362. (Pubitemid 19117877)
6. KUOG,CHOOQ-L, ALTER HJ et al.:Anassay for circulating antibodies to a major etiologic virus of human non-A, non-B antibodies. Science (1989) 244:362-364. (Pubitemid 19117878)
7. INTERNATIONAL UNION OF MICROBIOLOGICAL SOCIETIES: In: Virus Taxonomy (7th Edition). Murphy FA, Fauquet CM, Bishop DHL et al. (Eds.), Springer-Verlag, New York (1995):424-427.
8. HIJIKATA M, SHIMIZU YK, KATOHet al.: Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J. Virol. (1993) 67:1953-1958. (Pubitemid 23088368)
9. TSUKIYAMA-KOHARA K, LIZUKA N, KOHARA M, NOMOTO A: Internal ribosome entry site within hepatitis C virus RNA. J. Virol. (1992) 66:1476-1483.
10. TANAKA T, KATO N, CHO M-J, SHIMOTOHNO K: A novel sequence found at the 3¢ terminus of hepatitis C virus genome. Biochem. Biophys. Res. Commun. (1995) 215:744-749.
11. KOLYKHALOV AA, FEINSTONE SM, RICE C: Identification of a highly conserved sequence element at the 3¢ terminus of hepatitis C virus genome RNA. J. Virol. (1996) 70:3363-3371.
12. HIJIKATA M, KATO N, OOTSUYAMA Y, NAKAGAWA M, SHIMOTOHNO K: Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc. Natl. Acad. Sci. USA (1991) 88:5547-5551. (Pubitemid 21914782)
13. RALSTON R,THUDIUM K, BERGER Ket al.: Characterization of hepatitisCvirus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. J. Virol. (1993) 67:6753-6761. (Pubitemid 23309145)
14. SHIH CM, LO SJ, MIYAMURA T, CHEN SY, LEE YW: Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in Huh-7 cells. J. Virol. (1993) 67:5823-5832. (Pubitemid 23277490)
15. RAY RB, MEYER K, RAY R: Suppression of apoptotic cell death by hepatitis C virus core protein. Virology (1996) 176:182-185.
16. BARBA G,HARPER F,HARADA T et al.: HepatitisCvirus core protein shows a cytoplasmic localization and associates to cellular lipid storage droplets. Proc. Natl. Acad. Sci.USA(1997) 94:1200-1205. (Pubitemid 27087828)
17. LO SY, SELBY MJ, OU JH: Interaction between hepatitis C virus core protein and E1 envelope protein. J. Virol. (1996) 70:5177-5182. (Pubitemid 26240689)
18. MATSUURA Y, SUZUKI T, SUZUKI R et al.: Processing of E1 and E2 glycoproteins of hepatitis C virus expressed in mammalian and insect cells. Virology (1994) 205:141-150. (Pubitemid 24360600)
19. SELBY MJ, GLAZER E, MASIARZ F, HOUGHTON M: Complex processing and protein:protein interactions in the E2:NS2 region of HCV. Virology (1994) 204:114-122.
20. KUMAR U, MONJARDINO J, THOMAS HC: Hypervariable region of hepatitis C virus envelope glycoprotein (E2/NS1) in a gammaglobulinemic patient. Gastroenterology (1994) 106:1072-1075. (Pubitemid 24109297)
21. WEINER AJ, BRAUER MJ, ROSENBLATT J et al.: Variable and hypervariable domains are found in the regions of HCV corresponding to the Flavivirus envelope and NS1 proteins and the Pestivirus envelope glycoproteins. Virology (1991) 180:842-848.
22. OGATAN, ALTER HJ, MILLER RH, PURCELL RH: Nucleotide sequence and mutation rate of H strain of hepatitis C virus. Proc. Natl. Acad. Sci. USA (1991) 88:3392-3396. (Pubitemid 21916627)
23. HIJIKATA M, MIZUSHIMA H, AKAGI et al.: Two distinct proteinase activities required for the processing of a putative nonstructural precursor protein of the hepatitisCvirus. J. Virol. (1993) 67:4665-4675. (Pubitemid 23215946)
24. GRAKOUI A, MCCOURT DW, WYCHOWSKI SM, FEINSTONE SM, RICE CM: A second hepatitis C virus-encoded protease. Proc. Natl. Acad. Sci. USA (1993) 90:10583-10587.
25. WUZ,YAON, LE HV, WEBER PC: Mechanism of autoproteolysis at the NS2-NS3 junction of the hepatitis C virus polyprotein. Trends Biochem. Sci. (1998) 23:92-94. (Pubitemid 128712692)
26. RAWLINGS ND, BARRETT AJ: Families of cysteine peptidases. Methods Enzymol. (1994) 244:461-486.
27. GORBALENYA AE, SNIJDER EJ: Viral cysteine proteinases. Perspect. Drug Disc. Design (1996) 6:64-86. (Pubitemid 126484496)
28. SANTOLIN IE, PACINI L, FIPALDINI C,MIGLIACCI OG,LAMONICA N: TheNS2protein of hepatitis C virus is a transmembrane polypeptide. J. Virol. (1995) 69:7461-7471.
29. CLARKE B: Molecular virology of hepatitis C virus. J. Gen. Virol. (1997) 78:2397-2410. (Pubitemid 27469980)
30. PIERONI L, SANTOLINI E, FIPALDINI C et al.: In vitro study of the NS2-3 protease of hepatitis C virus. J. Virol. (1997) 71:6373-6380. (Pubitemid 27355290)
31. GRAKOUI A, MCCOURT DW, WYCHOWSKI SM, FEINSTONE SM, RICE CM: Characterization of the hepatitis C virus-encoded serine proteinase: determination of the proteinase-dependent polyprotein cleavage sites. J. Virol. (1993) 67:2832-2843. (Pubitemid 23118883)
32. FAILLA C, TOMEI L, DE FRANCESCO R: Both NS3 and NS4A are required for proteolytic processing of hepatitis C virus nonstructural proteins. J. Virol. (1994) 68:3753-3760. (Pubitemid 24177400)
33. SALI DL, INGRAM R, WENDEL M et al.: Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex. Biochemistry (1998) 37:3392-3401. (Pubitemid 28125567)
34. ZHANG R, DURKIN J, WINDSOR WTet al.: Probing the substrate specificity of hepatitis C virus NS3 serine protease by using synthetic peptides. J. Virol. (1997) 71:6208-6213. (Pubitemid 27304966)
35. LOVE RA, PARGE HE, WICKERSHAM JA et al.: The crystal structure of hepatitis C virus NS3 proteinase reveals a trypsin-like fold and a structural zinc binding site. Cell (1996) 87:331-342. (Pubitemid 26359010)
36. KIM JL, MORGENSTERN C, LIN T et al.: Crystal structure of the hepatitis C virus NS3 protease domain complexed with a syntheticNS4Acofactor peptide. Cell (1996) 87:343-355. (Pubitemid 26359011)
37. YAN Y, LI Y, MUNSHI S et al.: Complex of NS3 protease and NS4A peptide of BK strain hepatitis C virus: a 2.2 Å resolution structure in a hexagonal crystal form. Protein Sci. (1998) 7:837-847.
38. SUZICH JA, TAMURA JK, PALMER-HILL F et al.: Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related Pestivirus and Flavivirus enzymes. J. Virol. (1993) 67:6152-6158. (Pubitemid 23277527)
39. PREUGSCHAT F, AVERETT DR, CLARKE BE, PORTER DJT: A steady-state and pre-steady-state kinetic analysis of the NTPase activity associated with the hepatitis C virus NS3 helicase domain. J. Biol. Chem. (1996) 271:24449-24457. (Pubitemid 26333179)
40. TAI C-L, CHI W-K, CHEN D-S, HWANG L-H: The helicase activity associated with hepatitis C virus non structural protein 3 (NS3). J. Virol. (1996) 70:8477-8484. (Pubitemid 26378425)
41. KIM DW, KIM J,GWACK Y,HAN JH, CHOE J: Mutational analysis of the hepatitis C virus RNA helicase. J. Virol. (1997) 71:9400-9409. (Pubitemid 27492383)
42. HEILEK GM, PETERSON MG: A point mutation abolishes the helicase but not the nucleoside triphosphatase activity of hepatitis C virus NS3 protein. J. Virol. (1997) 71:6264-6266. (Pubitemid 27304977)
43. YA ON,HESSON T,CABLE Met al.: Structure of the hepatitisCvirusRNAhelicase domain. Nature Struct. Biol. (1997) 4:463-467.
44. KIM JL, MORGENSTERN KA, GRIFFITH JP et al.: Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding. Structure (1998) 6:89-100. (Pubitemid 28084402)
45. CHO H-S, HA N-C, KANG L-W et al.: Crystal structure of RNA helicase from genotype 1b hepatitis C virus. J. Biol. Chem. (1998) 273:15045-15052.
46. LIN C, THOMSON JA, RICE CM: A central region in the hepatitis C virus NS4A protein allows formation of an active NS3-NS4A serine proteinase complex in vivo and in vitro. J. Virol. (1995) 69:4373-4380.
47. TANJI Y, HIJIKATA M, SATOH S et al.: Hepatitis C virus-encoded nonstructural protein NS4A has versatile functions in viral protein processing. J. Virol. (1995) 69:1575-1581.
48. HIJIKATA M, MIZUSHIMA H, TANJI Y et al.: Proteolytic processing and membrane association of putative nonstructural proteins of hepatitisCvirus. Proc. Natl. Acad. Sci. USA (1993) 90:10773-10777. (Pubitemid 23347125)
49. ISHIDO S, FUJITA T,HOTTAH: Complex formation of NS5B with NS3 and NS4A proteins of hepatitis C virus. Biochem. Biophys. Res. Commun. (1998) 244:35-40. (Pubitemid 28419896)
50. TANJI Y, KANEKO T, SATOH S, SHIMOTOHNO K: Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. J. Virol. (1995) 69:3980-3986.
51. REED KE, GORBALENYA AE, RICE CM: The NS5A/NS5 proteins of viruses from three genera of the family Flaviviridae are phosphorylated by associated serine/threonine kinases. J. Virol. (1998) 72:6199-6206. (Pubitemid 28283416)
52. KATO N,LAN K-H, ONO-NITA SK et al.: HepatitisCvirus nonstructural region 5A protein is a potent transcriptional activator. J. Virol. (1997) 71:8856-8859. (Pubitemid 27446471)
53. GALE MJ, Jr., KORTH MJ, TANG NM et al.: Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology (1997) 230:217-227. (Pubitemid 27211852)
54. POCH O, SAUVAGER I, DELARUE M, TORDO N: Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. EMBO J. (1989) 8:3867-3874. (Pubitemid 20016069)
55. BEHRENS S-K, TOMEI L, DE FRANCESCO R: Identification and properties of the RNA-dependent RNA polymerase of hepatitis C virus. EMBO J. (1996) 15:12-22. (Pubitemid 26020384)
56. LOHMAN NV, KORNER F, HERIAN U, BARTENSCHLAGER R: Biochemical properties of hepatitisCvirus NS5B RNA-dependentRNApolymerase and identification of amino acid sequence motifs essential for enzymatic activity. J. Virol. (1997) 71:8416-8428. (Pubitemid 27446422)
57. YUAN Z-H, KUMAR U, THOMAS HC et al.: Expression, purification, and partial characterization of HCV RNA polymerase. Biochem. Biophys. Res. Commun. (1997) 232:231-235. (Pubitemid 27211954)
58. YAMASHITA T, KANEKO S, SHIROTA Y et al.: RNA-dependent RNA polymerase activity of the soluble recombinant hepatitis C virus NS5B protein truncated at the C-terminal region. J. Biol. Chem. (1998) 273:15479-15486. (Pubitemid 28298156)
59. HWANG SB, PARK K-J, KIM Y-S et al.: Hepatitis C virus NS5B protein is a membrane-associated phosphoprotein with a predominantly perinuclear localization. Virology (1997) 227:439-446. (Pubitemid 27241037)
60. SUDO K, MATSUMOTO Y, MATSUSHIMA M et al.: Novel hepatitis C virus protease inhibitors: 2,4,6-trihydroxy,3-nitro-benzamide derivatives. Antiviral Chem. Chemother. (1997) 8:541-544. (Pubitemid 27504719)
61. SUDO K, MATSUMOTO Y, MATSUSHIMA M et al.: Novel hepatitis C virus protease inhibitors: 2,4,6-trihydroxy,3-nitro-benzamide derivatives. Antiviral Chem. Chemother. (1998) 9:186.
62. SUDO K, MATSUMOTO Y, MATSUSHIMA M et al.: Novel hepatitis C virus protease inhibitors: thiazolidine derivatives. Biochem. Biophys. Res. Commun. (1997) 238:643-647. (Pubitemid 27464443)
63. KAKIUCHI N, KOMODA Y, KOMODA K et al.: Non-peptide inhibitors of HCV serine proteinase. FEBS Lett. (1998) 421:217-220. (Pubitemid 28045757)
64. HAHM B, HAN DS, BACK SH et al.: NS3-4A of hepatitis C virus is a chymotrypsin-like protease. J. Virol. (1995) 69:2534-2539.
65. STEINKUHLER C, BIASIOL G, BRUNETTI M et al.: Product inhibition of the hepatitis C virus NS3 protease. Biochemistry (1998) 37:8899-8905. (Pubitemid 28299658)
66. LLINAS-BRUNET M, BAILEY M, FAZAL G et al.: Peptide-based inhibitors of the hepatitis C virus serine protease. Bioorg. Med. Chem. Lett. (1998) 8:1713-1718. (Pubitemid 28341617)
67. INGALLINELLA P, ALTAMURA S, BIANCHI E et al.: Potent peptide inhibitors of human hepatitis C virus NS3 protease are obtained by optimizing the cleavage products. Biochemistry (1998) 37:8906-8914. (Pubitemid 28299659)
68. KUMAR PKR,MACHIDA K, URVIL PT et al.: Isolation ofRNAaptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA. Virology (1997) 237:270-282. (Pubitemid 27489266)
69. URVIL P, KAPIUCHI N,ZHOUD-Met al.: Selection ofRNAaptamers that bind specifically to the NS3 protease of hepatitis C virus. Eur. J. Biochem. (1997) 248:130-138. (Pubitemid 27356980)
70. DIMASSI N,MARTIN F, VOLPARI Cet al.: Characterization of engineered hepatitisCvirus NS3 protease: inhibitors selected from human pancreatic secretory trypsin inhibitor and minibody repertoire. J. Virol. (1997) 71:7461-7469. (Pubitemid 27391686)
71. MARTIN F, DIMASI N, VOLPARI C et al.: Design of selective Eglin inhibitors of HCV NS3 proteinase. Biochemistry (1998) 37:11459-11468. (Pubitemid 28388187)
72. SUZICH JA, TAMURA JK, PALMER-HILL F et al.: Hepatitis C virus NS3 protein polynucleotide-stimulated nucleoside triphosphatase and comparison with the related Pestivirus and Flavivirus enzymes. J. Virol. (1993) 67:6152-6158. (Pubitemid 23277527)
73. TAI C-L, CHI W-K, CHEN D-S, HWANG L-H: The helicase activity associated with hepatitis C virus non structural protein 3 (NS3). J. Virol. (1996) 70:8477-8484. (Pubitemid 26378425)
74. KANAI A, KYOKO T, MICHINORI K: Poly(U) binding activity of hepatitis C virus NS3 protein, a putative RNA helicase. FEBS Lett. (1995) 376:221-224.
75. LE HV, YAO NH, MURGOLO N, WEBER PC: The structure of HCV RNA helicase and its relevance to the design of new anti-HCV drugs. Hepatologia Clinica (In press).
76. KOROLEV S, YAO N, LOHMAN TM, WEBER PC, WAKSMAN G: Comparisons between the structures ofHCVand Rep helicases reveal structural similarities between SF1 and SF2 super-families of helicases. Protein Sci. (1998) 7:605-610. (Pubitemid 28130882)
77. HANSEN JL,LONG AM,SCHULTZ SC: Structure of the RNA-dependentRNApolymerase of poliovirus. Structure (1997) 5:1109-1122.
78. WANG C,SARNOW P, SIDDIQUI A: Translation of hepatitisCvirusRNAin cultured cells is mediated by an internal ribosome-binding mechanism. J. Virol. (1998) 67:3338-3344. (Pubitemid 23143708)
79. DAS S, OTT M, YAMANE A et al.: A small yeast RNA blocks hepatitis C virus internal ribosome entry site (HCV IRES)-mediated translation and inhibits replication of a chimeric poliovirus under translational control of the HCV IRES element. J. Virol. (1998) 72:5638-5647. (Pubitemid 28283348)
80. RADHAKRISHNAN R, WALTER LJ, HRUZA A et al.: Zinc mediated dimer of human interferon-a2b revealed by X-ray crystallography. Structure (1996) 4:1453-1463. (Pubitemid 27050278)